A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Circulating Tumor DNA Exposure in Peripheral Blood
- Status
- UNKNOWN
- Phase
- N/A
Management of Spontaneous Ruptured Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Expanding Phase III Study of Tyroserleutide for Injection
- Status
- UNKNOWN
- Phase
- PHASE3
Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Microbiota Study in Liver Transplanted Patients
- Status
- COMPLETED
- Phase
- N/A
Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test
- Status
- UNKNOWN
- Phase
- N/A
Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation
- Status
- COMPLETED
- Phase
- N/A
HCC Screening Using DNA Methylation Changes in ctDNA
- Status
- COMPLETED
- Phase
- N/A
Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
R1vascular Hepatectomy for HCC Patients
- Status
- COMPLETED
- Phase
- N/A
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria
- Status
- UNKNOWN
- Phase
- PHASE3
HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE3
A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib in Patients With Advanced HCC(RESCUE)
- Status
- COMPLETED
- Phase
- PHASE2
Diagnostic Value of AFP-L3 and PIVKA-II in HCC
- Status
- UNKNOWN
- Phase
- N/A
Determination of Autonomic Responses to the Exposure of Low Energy Electromagnetic Fields With Frequency Modulation in Patients With Advanced Hepatocellular Carcinoma and Healthy Individuals.
- Status
- RECRUITING
- Phase
- NA